Jane Street Group, LLC Ligand Pharmaceuticals Inc Call Options Transaction History

Jane Street Group, LLC

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 16, 2022	SELL	$74.52 - $117.06 $819,720 - $1.29 Million	-11,000 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$94.99 - $151.56 $2.46 Million - $3.93 Million	-25,900 Reduced 70.19%	11,000 $1.24 Million
Q4 2021 Feb 15, 2022	SELL	$127.69 - $165.85 $472,453 - $613,645	-3,700 Reduced 9.11%	36,900 $5.7 Million
Q3 2021 Nov 16, 2021	SELL	$102.33 - $144.73 $1.22 Million - $1.72 Million	-11,900 Reduced 22.67%	40,600 $5.66 Million
Q2 2021 Aug 16, 2021	SELL	$113.03 - $155.64 $2.83 Million - $3.89 Million	-25,000 Reduced 32.26%	52,500 $6.89 Million
Q1 2021 May 18, 2021	BUY	$99.52 - $215.83 $6.61 Million - $14.3 Million	66,400 Added 598.2%	77,500 $11.8 Million
Q4 2020 Feb 17, 2021	BUY	$80.55 - $106.05 $128,880 - $169,680	1,600 Added 16.84%	11,100 $1.1 Million
Q3 2020 Nov 17, 2020	SELL	$89.56 - $126.72 $7.66 Million - $10.8 Million	-85,500 Reduced 90.0%	9,500 $906,000
Q2 2020 Aug 17, 2020	SELL	$68.28 - $123.65 $839,844 - $1.52 Million	-12,300 Reduced 11.46%	95,000 $10.6 Million
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $6.15 Million - $10.5 Million	97,100 Added 951.96%	107,300 $7.8 Million
Q4 2019 Feb 14, 2020	BUY	$96.94 - $113.59 $348,984 - $408,924	3,600 Added 54.55%	10,200 $1.06 Million
Q1 2019 May 16, 2019	BUY	$105.93 - $142.47 $413,127 - $555,633	3,900 Added 144.44%	6,600 $830,000
Q4 2018 Feb 15, 2019	BUY	$128.36 - $272.13 $346,572 - $734,751	2,700 New	2,700 $366,000

277

18.5M

30.8K

5.2K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.83B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.